Legend Biotech Corporatio...

37.47
2.80 (8.08%)
At close: Jan 22, 2025, 3:59 PM
37.62
0.40%
After-hours Jan 22, 2025, 04:00 PM EST

Legend Biotech Corporation Statistics

Share Statistics

Legend Biotech Corporation has 183.45M shares outstanding. The number of shares has increased by 0.85% in one year.

Shares Outstanding 183.45M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.15%
Owned by Institutions (%) n/a
Shares Floating 181.93M
Failed to Deliver (FTD) Shares 671
FTD / Avg. Volume 0.05%

Short Selling Information

The latest short interest is 22.95M, so 12.51% of the outstanding shares have been sold short.

Short Interest 22.95M
Short % of Shares Out 12.51%
Short % of Float 12.61%
Short Ratio (days to cover) 15.37

Valuation Ratios

The PE ratio is -20.44 and the forward PE ratio is -59.97.

PE Ratio -20.44
Forward PE -59.97
PS Ratio 37.16
Forward PS 4.5
PB Ratio 8.47
P/FCF Ratio -25.47
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Legend Biotech Corporation has an Enterprise Value (EV) of 9.65B.

EV / Earnings -18.61
EV / Sales 33.83
EV / EBITDA -20.18
EV / EBIT -21.95
EV / FCF -23.19

Financial Position

The company has a current ratio of 6.92, with a Debt / Equity ratio of 0.26.

Current Ratio 6.92
Quick Ratio 6.83
Debt / Equity 0.26
Total Debt / Capitalization 20.8
Cash Flow / Debt -1.2
Interest Coverage -20.17

Financial Efficiency

Return on equity (ROE) is -0.41% and return on capital (ROIC) is -27.72%.

Return on Equity (ROE) -0.41%
Return on Assets (ROA) -0.28%
Return on Capital (ROIC) -27.72%
Revenue Per Employee 118.81K
Profits Per Employee -215.94K
Employee Count 2.40K
Asset Turnover 0.15
Inventory Turnover 7.42

Taxes

Income Tax -1.86M
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -37.65% in the last 52 weeks. The beta is 0.11, so Legend Biotech Corporation's price volatility has been higher than the market average.

Beta 0.11
52-Week Price Change -37.65%
50-Day Moving Average 36.97
200-Day Moving Average 45.89
Relative Strength Index (RSI) 60.09
Average Volume (20 Days) 1.47M

Income Statement

In the last 12 months, Legend Biotech Corporation had revenue of 285.14M and earned -518.25M in profits. Earnings per share was -2.94.

Revenue 285.14M
Gross Profit 140.93M
Operating Income -439.49M
Net Income -518.25M
EBITDA -477.87M
EBIT -439.49M
Earnings Per Share (EPS) -2.94
Full Income Statement

Balance Sheet

The company has 1.28B in cash and 328.67M in debt, giving a net cash position of 949.04M.

Cash & Cash Equivalents 1.28B
Total Debt 328.67M
Net Cash 949.04M
Retained Earnings -1.48B
Total Assets 1.74B
Working Capital 1.08B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -393.28M and capital expenditures -22.72M, giving a free cash flow of -416.00M.

Operating Cash Flow -393.28M
Capital Expenditures -22.72M
Free Cash Flow -416.00M
FCF Per Share -2.36
Full Cash Flow Statement

Margins

Gross margin is 49.42%, with operating and profit margins of -154.13% and -181.75%.

Gross Margin 49.42%
Operating Margin -154.13%
Pretax Margin -182.41%
Profit Margin -181.75%
EBITDA Margin -167.59%
EBIT Margin -154.13%
FCF Margin -145.89%

Dividends & Yields

LEGN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -7.85%
FCF Yield -6.05%
Dividend Details

Analyst Forecast

The average price target for LEGN is $84.5, which is 125.5% higher than the current price. The consensus rating is "Buy".

Price Target $84.5
Price Target Difference 125.5%
Analyst Consensus Buy
Analyst Count 13
Stock Forecasts

Scores

Altman Z-Score 4.87
Piotroski F-Score 4